LIFE Financing and Concurrent Private Placement to Include Common Shares Only and no Warrants
Toronto, Ontario–(Newsfile Corp. – September 27, 2024) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma Bright” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that it will be conducting a non-brokered listed issuer financing exemption (LIFE) private placement of up to CAD$3,000,000 through the issuance of up to 50,000,000 common shares of the Company at a price of CAD$0.06 per share (the “LIFE Financing”). Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), the LIFE Financing is being made to purchasers resident in each of the Provinces of Canada, except Quebec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the “LIFE Exemption”).
Expanding Horizons with LIFE Financing
Therma Bright’s decision to conduct a non-brokered listed issuer financing exemption (LIFE) private placement marks a significant step for the company. By offering up to 50,000,000 common shares at an attractive price of CAD$0.06 per share, Therma Bright is providing investors with a unique opportunity to participate in its growth and development.
With a focus on cutting-edge diagnostic and medical device technologies, Therma Bright is at the forefront of innovation in the healthcare industry. The funds raised through the LIFE Financing will enable the company to further its research and development efforts, bringing new and advanced solutions to market.
Impact on Investors
For investors, the LIFE Financing presents a chance to support a company committed to making a difference in the world of healthcare. By investing in Therma Bright, individuals have the opportunity to be part of groundbreaking advancements in diagnostic and medical device technologies, while also potentially benefiting from the company’s growth and success.
Impact on the Healthcare Industry
The LIFE Financing has the potential to have a ripple effect on the healthcare industry as a whole. With Therma Bright’s continued focus on innovation and the development of cutting-edge technologies, the industry could see new and improved solutions that have the power to transform patient care and outcomes.
How This Affects Me
As an investor, the LIFE Financing provides an opportunity to support a company at the forefront of healthcare innovation. By investing in Therma Bright, you can play a role in advancing cutting-edge technologies that have the potential to make a significant impact in the industry.
How This Affects the World
The LIFE Financing has the potential to drive advancements in the healthcare industry that could benefit people around the world. By funding research and development efforts, Therma Bright is paving the way for new solutions that have the power to improve patient care and treatment outcomes on a global scale.
Conclusion
In conclusion, Therma Bright’s LIFE Financing represents a key milestone for the company and the healthcare industry as a whole. By offering common shares through a non-brokered private placement, Therma Bright is opening up new possibilities for investors to support innovation and drive positive change in the world of healthcare.
